121 related articles for article (PubMed ID: 17894092)
1. In vitro approaches to the pathogenetic mechanisms of multiple sclerosis by leukocyte migration inhibition.
Smeraldi E; Cazzullo CL; Zibetti A; Bottinelli S
Dis Nerv Syst; 1974 Jul; 35(7):335-9. PubMed ID: 17894092
[No Abstract] [Full Text] [Related]
2. Effect of bilirubin on an in vitro correlate of cell-mediated immunity--the migration inhibition test.
Svejcar J; Miler I; Pekárek J
J Clin Lab Immunol; 1984 Mar; 13(3):145-9. PubMed ID: 6371239
[TBL] [Abstract][Full Text] [Related]
3. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis].
Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte inhibitory factor (LIF) production from lymphocytes stimulated by leucogenenol.
Fumarola D; Jirillo E; De Rinaldis P; Pasquetto N; Monno R; Munno I
Boll Ist Sieroter Milan; 1977 Mar; 56(2):126-31. PubMed ID: 326269
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin effect on lymphokine production in multiple sclerosis.
Willoughby EW; Dupont B; Good RA
Ann Neurol; 1979 Apr; 5(4):391-3. PubMed ID: 375809
[TBL] [Abstract][Full Text] [Related]
6. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
7. [Agarose test of leukocyte migration inhibition].
Kaszubowski P; Wysocki J
Wiad Lek; 1979 Nov; 32(22):1621-3. PubMed ID: 395757
[No Abstract] [Full Text] [Related]
8. The migration inhibition of human T lymphocytes -- immunological and clinical implications.
Zembala M; Kowalczyk D
Mater Med Pol; 1981; 13(3):152-8. PubMed ID: 6980335
[No Abstract] [Full Text] [Related]
9. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
Carnegie PR; Caspary EA; Dickinson JP; Field EJ
Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
[TBL] [Abstract][Full Text] [Related]
10. [Leukocyte migration inhibition by endotoxins on Clausen's agarose plates].
De Rinaldis P; Jirillo E; Pantaleo R; Fumarola D
G Batteriol Virol Immunol; 1974; 67(7-12):238-45. PubMed ID: 4619604
[No Abstract] [Full Text] [Related]
11. Lack of correspondence between virus-induced human leukocyte interferon and concanavalin A-induced human migration inhibitory factor (MIF).
Block LH; Cantell K; Bamberger S; Ruhenstroth-Bauer G; Strander H
Arch Virol; 1978; 56(4):341-3. PubMed ID: 348158
[No Abstract] [Full Text] [Related]
12. [Changes in the immunological indices during the antibacterial and pathogenetic therapy of pulmonary tuberculosis].
Spesivtsev OG; Telkova GV; Gal'chanskaia LD; Sobolevskaia LI
Probl Tuberk; 1980 Sep; (9):34-8. PubMed ID: 7422654
[No Abstract] [Full Text] [Related]
13. [Tests on the production of the migration inhibitory factor of macrophages in disseminated cerebrospinal sclerosis].
Jedlicka P; Pekárek J; Svejcar J
Cesk Neurol Neurochir; 1978 Jul; 41(4):235-42. PubMed ID: 352548
[No Abstract] [Full Text] [Related]
14. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.
Górski AJ; Dupont B; Hansen JA; Good RA
Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3197-200. PubMed ID: 1103141
[TBL] [Abstract][Full Text] [Related]
15. [Studies on mechanisms of tuberculin hypersensitivity. I. The relation between the functions of cells mediating tuberculin-type hypersensitivity (TTH) and the infiltrating cells in skin reaction site (author's transl)].
Oyamaguchi A
Kekkaku; 1982 Feb; 57(2):59-71. PubMed ID: 7040775
[No Abstract] [Full Text] [Related]
16. Similarity of migration inhibitory factor(s) produced by human lymphoid cell line and phytohemagglutinin and tuberculin-stimulated human peripheral lymphocytes.
Papageorgiou PS; Sorokin CF; Glade PR
J Immunol; 1974 Feb; 112(2):675-82. PubMed ID: 4591976
[No Abstract] [Full Text] [Related]
17. The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis.
Jalosinski M; Karolczak K; Mazurek A; Glabinski A
Acta Neurol Scand; 2008 Aug; 118(2):120-5. PubMed ID: 18336625
[TBL] [Abstract][Full Text] [Related]
18. [Unsaturated fatty acids in the immunology and therapy of multiple sclerosis].
Cendrowski W
Pol Tyg Lek; 1982 Apr; 37(8):225-7. PubMed ID: 7050947
[No Abstract] [Full Text] [Related]
19. Cellular immunity in multiple sclerosis.
Rysková O; Vejbora O; Chromová L; Pekárek J; Chmelar V; Zaydlar K
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(1):85-91. PubMed ID: 6975970
[No Abstract] [Full Text] [Related]
20. Intrathecal administration of purified protein derivative of tuberculin. Observation of serum and CSF proteins in patients with multiple sclerosis.
GAVRILESCU K; JELLINEK EH; McMENEMEY WH
World Neurol; 1961 Aug; 2():709-18. PubMed ID: 13704049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
